Premium
Medical devices as a viable option for preventing and treating OUD
Publication year - 2019
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30361
Subject(s) - food and drug administration , opioid use disorder , agency (philosophy) , opioid abuse , medicine , addiction , business , opioid , psychiatry , medical emergency , sociology , social science , receptor
The Food and Drug Administration (FDA) has awarded eight companies “Innovation Challenge” grants to spur the development of medical devices, including diagnostic tests and mobile medical applications, to prevent and treat opioid use disorder (OUD). The FDA launched the challenge last spring, and there were more than 250 applications. “The FDA remains committed to addressing this national crisis on all fronts, with a focus on encouraging medical product innovation to prevent new cases of opioid abuse and addiction and to treat those addicted,” the agency stated in announcing the grants last month.